Related Experiment Video
Updated: Sep 4, 2025

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
Published on: September 23, 2021
Extracellular vesicles for improved tumor accumulation and penetration
Nana Bie1, Tuying Yong1, Zhaohan Wei1
1National Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430074, China; Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430074, China.
Extracellular vesicles (EVs) show promise for targeted tumor drug delivery. Strategies enhance EV accumulation and penetration into deep tumors, addressing key challenges for clinical use.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Extracellular vesicles (EVs), encompassing microparticles and exosomes, are increasingly recognized for their potential in targeted tumor drug delivery.
- Significant advancements have been made in strategies to improve EV accumulation and penetration within deep tumor tissues.
Purpose of the Study:
- To review current strategies for enhancing tumor accumulation and penetration of EVs as drug delivery systems.
- To explore the role of innate EV characteristics and various engineering approaches in improving drug delivery efficacy.
- To discuss methods for modulating EV biological functions to facilitate tumor penetration.
Main Methods:
- Summarization of EVs from diverse cell origins with distinct inherent properties.
- Analysis of engineered approaches including chemical, genetical, and biomimetic engineering for EV modification.
- Review of biological function modulation techniques such as extracellular matrix degradation, mechanical property regulation, and transcytosis enhancement.
Main Results:
- Engineered EVs and modulated biological functions significantly enhance tumor accumulation and penetration.
- Diverse strategies leverage innate EV properties and external modifications for improved drug delivery.
- Biological function modulation aids in overcoming tumor barriers for deeper drug distribution.
Conclusions:
- EVs represent a promising platform for advanced tumor-targeted drug delivery.
- Further research and development are crucial to overcome existing challenges for successful clinical translation.
- Optimizing EV engineering and biological modulation holds potential for next-generation cancer therapies.
More Related Videos
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Tumor Microenvironment
Cancer Cell Migration through Invadopodia
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...

